MXPA03005885A - Procedimiento para fabricar maleato de amlodipina. - Google Patents

Procedimiento para fabricar maleato de amlodipina.

Info

Publication number
MXPA03005885A
MXPA03005885A MXPA03005885A MXPA03005885A MXPA03005885A MX PA03005885 A MXPA03005885 A MX PA03005885A MX PA03005885 A MXPA03005885 A MX PA03005885A MX PA03005885 A MXPA03005885 A MX PA03005885A MX PA03005885 A MXPA03005885 A MX PA03005885A
Authority
MX
Mexico
Prior art keywords
amlodipine
amlodipine maleate
making
maleate
making amlodipine
Prior art date
Application number
MXPA03005885A
Other languages
English (en)
Inventor
Slanina Pavel
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29740325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA03005885(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of MXPA03005885A publication Critical patent/MXPA03005885A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Abstract

Un procedimiento para fabricar maleato de amlodipina que comprende hacer reaccionar amlodipina o una sal de adicion acida de la misma con acido maleico, bajo un ambiente acido para formar un producto de maleato de amlodipina; el procedimiento permite la formacion de maleato de amlodipina sustancialmente libre de aspartato de amlodipina.
MXPA03005885A 2000-12-29 2001-08-15 Procedimiento para fabricar maleato de amlodipina. MXPA03005885A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25861200P 2000-12-29 2000-12-29
US80934301A 2001-03-16 2001-03-16
PCT/NL2001/000607 WO2002053542A1 (en) 2000-12-29 2001-08-15 Process for making amlodipine maleate
BE2001/0709A BE1014452A6 (nl) 2000-12-29 2001-11-05 Werkwijze voor het maken van amlodipinemaleaat.

Publications (1)

Publication Number Publication Date
MXPA03005885A true MXPA03005885A (es) 2005-04-19

Family

ID=29740325

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005885A MXPA03005885A (es) 2000-12-29 2001-08-15 Procedimiento para fabricar maleato de amlodipina.

Country Status (25)

Country Link
US (2) US6600047B2 (es)
EP (1) EP1309555B1 (es)
CN (1) CN1272319C (es)
AP (1) AP2003002820A0 (es)
AT (3) ATE300520T1 (es)
BE (1) BE1014452A6 (es)
BR (1) BR0116557A (es)
CA (1) CA2433288C (es)
DE (2) DE60112305T2 (es)
DK (3) DK1309555T3 (es)
ES (1) ES2243553T3 (es)
FI (1) FI6788U1 (es)
HK (2) HK1055965A1 (es)
HR (1) HRP20030526A2 (es)
IL (1) IL156692A0 (es)
IS (1) IS6834A (es)
MA (1) MA25984A1 (es)
MX (1) MXPA03005885A (es)
NO (1) NO20032518L (es)
NZ (1) NZ526506A (es)
PL (1) PL362660A1 (es)
PT (1) PT1309555E (es)
RS (1) RS53403A (es)
SI (1) SI1309555T1 (es)
WO (1) WO2002053542A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03005886A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Derivado de aspartato de amlodipina como antagonista del canal de calcio.
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
MXPA03005882A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Derivado amida de amlodipina.
AP2003002820A0 (en) 2000-12-29 2003-06-30 Pfizer Ltd "Process for making amlodipine maleate"
CA2433193C (en) * 2000-12-29 2006-01-31 Pfizer Limited Amide derivative of amlodipine
US20030027848A1 (en) * 2001-06-15 2003-02-06 Anne Billotte Stabilized formulations
GB0114709D0 (en) * 2001-06-15 2001-08-08 Pfizer Ltd Stabilised formulations of amlodipine maleate
US20030180354A1 (en) * 2001-10-17 2003-09-25 Dr. Reddy's Laboratories Limited Amlodipine maleate formulations
KR100496436B1 (ko) 2002-07-30 2005-06-20 씨제이 주식회사 암로디핀의 유기산염
KR100538641B1 (ko) * 2002-07-30 2005-12-22 씨제이 주식회사 암로디핀의 유기산염
KR100467669B1 (ko) 2002-08-21 2005-01-24 씨제이 주식회사 암로디핀의 유기산염
AU2003253460A1 (en) * 2002-09-19 2004-04-08 Cj Corporation Crystalline organic acid salt of amlodipine
EP1407773A1 (en) * 2002-10-08 2004-04-14 Council of Scientific and Industrial Research A process for the preparation of s (-) amlodipine salts
US20040072879A1 (en) * 2002-10-10 2004-04-15 Dr. Reddy's Laboratories Limited Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
AU2002368531A1 (en) * 2002-12-30 2004-07-22 Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. Isolation of dihydropyridine derivative and preparation salts thereof
WO2005023769A1 (en) * 2003-09-04 2005-03-17 Cipla Limited Process for the preparation of amlodipine salts
EP1687273A1 (en) * 2003-11-20 2006-08-09 Council Of Scientific And Industrial Research Process for preparation of chiral amlodipine salts
US20060035940A1 (en) * 2004-03-16 2006-02-16 Sepracor Inc. (S)-Amlodipine malate
CA2667488C (en) * 2006-11-02 2015-07-07 Millennium Pharmaceuticals, Inc. Methods of synthesizing pharmaceutical salts of a factor xa inhibitor
KR100843400B1 (ko) * 2006-11-14 2008-07-04 씨제이제일제당 (주) 결정성 ｓ-(-)-암로디핀 말레익산 염 무수물 및 이의제조방법
US20090062352A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched amlodipine
CN102344409B (zh) * 2011-07-20 2013-04-03 海南锦瑞制药股份有限公司 一种氨氯地平晶体、其与贝那普利药用组合物及制备方法
CN102382041B (zh) * 2011-12-02 2016-01-20 东北制药集团股份有限公司 一种马来酸氨氯地平的制备方法
CN103044314A (zh) * 2013-01-06 2013-04-17 先声药业有限公司 马来酸氨氯地平的制备方法
CN104529877A (zh) * 2015-01-22 2015-04-22 华东理工常熟研究院有限公司 氨氯地平-癸酸离子液体及其制备方法和用途
EP3960158A1 (en) 2016-10-07 2022-03-02 Silvergate Pharmaceuticals, Inc. Amlodipine formulations
CN108358833A (zh) * 2018-03-15 2018-08-03 上海峰林生物科技有限公司 一种马来酸氨氯地平的合成工艺
JP7456933B2 (ja) 2018-04-11 2024-03-27 シルバーゲイト ファーマシューティカルズ，インク． アムロジピン製剤
CN109651236A (zh) * 2019-01-24 2019-04-19 浙江尖峰药业有限公司 门冬氨酸氨氯地平的晶型及其制备和应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294969A (en) * 1979-01-29 1981-10-13 Merck & Co., Inc. Process for producing 2-bromo-3,5-disubstituted pyridines
CS228917B2 (en) * 1981-03-14 1984-05-14 Pfizer Method of preparing substituted derivatives of 1,4-dihydropyridine
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
GR851819B (es) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
IT1201454B (it) * 1985-08-19 1989-02-02 Boehringer Biochemia Srl 1,4-diidropiridine-2-sostituite
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
FR2602231B1 (fr) * 1986-08-04 1988-10-28 Adir Nouveaux derives de la dihydro-1,4 pyridine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US4983740A (en) 1986-08-04 1991-01-08 Adir Et Compagnie Process for 1,4-dihydropyridine compounds
GB8710493D0 (en) 1987-05-02 1987-06-03 Pfizer Ltd Dihydropyridines
US5155120A (en) 1991-01-14 1992-10-13 Pfizer Inc Method for treating congestive heart failure
WO1993006082A1 (en) 1991-09-13 1993-04-01 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropyridines
US5389654A (en) 1992-11-26 1995-02-14 Lek, Tovarna, Farmacevtskih In Kemicnih . . . 3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
HU221810B1 (hu) 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
ZA9810320B (en) 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
ZA9810319B (en) * 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of acetal derivatives of 1,4-dihydropyridines, novel acetal derivatives and the use of the acetal derivatives for the preparation of other 1,4-dihydropyridines.
PL189666B1 (pl) * 1998-04-09 2005-09-30 Adamed Sp Z Oo Sposób otrzymywania benzenosulfonianu amlodypiny
GB9812413D0 (en) 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
ES2151850B1 (es) 1998-10-26 2001-08-16 Esteve Quimica Sa Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente.
GB9827431D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel compound
GB9827387D0 (en) 1998-12-11 1999-02-03 Smithkline Beecham Plc Novel process
CA2433193C (en) * 2000-12-29 2006-01-31 Pfizer Limited Amide derivative of amlodipine
MXPA03005884A (es) * 2000-12-29 2005-04-08 Pfizer Ltd Hemimaleato de amlodipina.
MXPA03005886A (es) * 2000-12-29 2005-04-19 Pfizer Ltd Derivado de aspartato de amlodipina como antagonista del canal de calcio.
AP2003002820A0 (en) * 2000-12-29 2003-06-30 Pfizer Ltd "Process for making amlodipine maleate"
CA2433181C (en) * 2000-12-29 2005-11-22 Pfizer Limited Amlodipine hemifumarate

Also Published As

Publication number Publication date
US20030199559A1 (en) 2003-10-23
CA2433288C (en) 2006-06-13
RS53403A (en) 2006-10-27
BE1014452A6 (nl) 2003-10-07
PL362660A1 (en) 2004-11-02
CA2433288A1 (en) 2002-07-11
DK200300344U1 (da) 2003-12-12
AT7109U3 (de) 2005-05-25
FIU20030476U0 (fi) 2003-12-17
FI6788U1 (fi) 2005-09-14
HK1055965A1 (en) 2004-01-30
DK200300345U3 (da) 2004-03-12
CN1505614A (zh) 2004-06-16
EP1309555B1 (en) 2005-07-27
AT7110U3 (de) 2005-05-25
EP1309555A1 (en) 2003-05-14
AP2003002820A0 (en) 2003-06-30
AT7110U9 (de) 2004-11-25
DK1309555T3 (da) 2005-10-24
IS6834A (is) 2003-05-30
US20020086888A1 (en) 2002-07-04
AT7109U2 (de) 2004-10-25
ES2243553T3 (es) 2005-12-01
ATE300520T1 (de) 2005-08-15
CN1272319C (zh) 2006-08-30
HRP20030526A2 (en) 2005-06-30
NO20032518L (no) 2003-06-26
BR0116557A (pt) 2003-10-28
DK200300344U4 (da) 2005-09-09
SI1309555T1 (sl) 2005-12-31
MA25984A1 (fr) 2003-12-31
NZ526506A (en) 2004-11-26
IL156692A0 (en) 2004-01-04
DE60112305D1 (de) 2005-09-01
DE60112305T2 (de) 2006-05-24
AT7110U2 (de) 2004-10-25
DE20115704U1 (de) 2002-02-14
US6600047B2 (en) 2003-07-29
NO20032518D0 (no) 2003-06-04
PT1309555E (pt) 2005-10-31
HK1064671A1 (en) 2005-02-04
WO2002053542A1 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
RS53403A (en) Process for making amlodipine maleate
IL148194A0 (en) A method of producing a compressed product
AU2001277545A1 (en) Process for the production of 2-hydroxy-4-methylmercaptobutyric acid
YU101103A (en) Technical synthesis method for producing tropenol
GB2377225B (en) Process for the production of low ash fuel
IL146811A0 (en) Novel method for preparing benzoperhydroisoindole compounds
SI1620423T1 (sl) Postopek za pripravo (4-hidroksi-6-okso-tetrahidro-piran-2-il)-aceetonitrila in njihovih derivatov
AU2956302A (en) A process for the preparation of taxan derivatives
HK1047093A1 (en) Process for production of naphthyridine-3-carboxyrlic acid derivatives.
EP1280745A4 (en) METHOD FOR PRODUCING GASOLINE COMPONENTS
CA2395420A1 (en) Method for production of n-phosphonomethylglycine
AU3453502A (en) A process for the preparation of paclitaxel
IL152295A0 (en) Method for producing 2-alkyl-3-chlorophenols
AU6584601A (en) Method for producing indols
ECSP034679A (es) Proceso para hacer el maleato de amlodipina
WO2002020490A3 (en) Process to produce halo-4-phenoxyquinolines
AU2001266323A1 (en) Process for the production of calcium pantothenate
AU5925498A (en) Processes for producing 3-cyanopyridine from 2-methyl-1,5-pentanediamine
JO2258B1 (en) Method for preparing hydroxamic acids
GB9907834D0 (en) Process for the production of carboxylic acid
WO2002018364A3 (en) Process for preparing 2-phenyl-3-aminobenzothiophenes
GB2349881B (en) A process for the production of 4-aryl-2 butanols
WO2003068765A3 (en) Improved process for the production of dihydropyridines
PL368635A1 (en) Process for the production of low ash fuel
HU0001287D0 (en) New intermediate and process for its production

Legal Events

Date Code Title Description
FA Abandonment or withdrawal